Minimally Invasive Surgery Market - In Depth Analysis by Size

Global Minimally Invasive Surgery Market Overview

The Global Minimally Invasive Surgery Market size is expected to grow from USD 63.18 Billion in 2023 to USD 139.39 Billion by 2032, at a CAGR of 9.19% during the forecast period (2024-2032).

Minimally Invasive Surgery (MIS) represents a transformative approach in modern surgical practices, characterized by procedures that minimize incisions and reduce recovery times compared to traditional open surgeries. These techniques involve the use of specialized instruments, including endoscopes, laparoscopes, and robotic systems, to perform surgeries with minimal damage to surrounding tissues. The global MIS market, valued at approximately USD 35 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 8% through 2030, driven by advancements in surgical technology, increasing patient preference for less invasive procedures, and the growing burden of chronic diseases.

Technological advancements are at the forefront of the MIS market's expansion. The development of robotic-assisted surgery, exemplified by systems like the da Vinci Surgical System, allows for enhanced precision, flexibility, and control during complex procedures. Innovations in imaging and visualization, such as 3D imaging and augmented reality (AR), are enhancing surgeons’ capabilities to perform intricate surgeries with greater accuracy. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in surgical planning and intraoperative guidance is transforming surgical practices, leading to improved outcomes and efficiency.

Market Dynamics and Key Factors of Minimally Invasive Surgery Market

Drivers:

The rise in the number of individuals suffering from cancer and cardiovascular diseases is the main factor promoting the expansion of the minimally invasive surgery market during the forecast period. Scars from minimally invasive surgery are smaller than the traditional open surgery. In laparoscopy, one incision is done in the belly button and one to three others in the lower belly. The hospital stay period is gradually reduced and it decreases the risk for problems such as blood clots or infection post-surgery thus, supporting the development of minimally invasive surgery market over the projected period.

Less and smaller incisions are made in minimally invasive surgery methods thereby, it is a less painful procedure than traditional open surgery methods. As the patient suffers less pain, the requirement for pain killers eventually decreases. Moreover, minimally invasive surgery increases the recovery time, and there is a high reduction in blood loss during surgery as small cuts are made. The growing awareness among individuals about the benefits of minimally invasive surgery methods is the essential factor stimulating the growth of the minimally invasive surgery market. According to a report published by NCBI, 310 million major surgeries are performed each year. This large number can be attributed to the rising adult population and the change in lifestyle that has fueled the rise in cardiovascular and other chronic disorders across every age group. Furthermore, the growing senior citizen population and their higher susceptibility to diseases that requires surgical procedures are promoting the expansion of the minimally invasive surgery market in the projected period.

Restraints:

The main factor hampering the expansion of the minimally invasive surgery market is the high cost associated with the surgical procedures. Moreover, stringent government rules and regulations while approving a novel technique to be administered in minimally invasive surgeries is another factor declining the growth of the market. Furthermore, robotic surgery a subtype of minimally invasive surgery method takes a longer time to set up the robotic equipment and sometimes may take a longer time than open surgery. There are possible risks associated with general anesthesia and infections as it pertains to any surgery thus, hindering the development of the minimally invasive surgery market during the projected period.

Opportunities:

The investments made by several governments and private organizations to develop novel surgery methods that can reduce the risk associated with the traditional open surgery methods is creating a lucrative opportunity for the market players. The trend is set to see an upsurge in demand as individuals are becoming aware of the advantages of minimally invasive surgery methods such as quick recovery time, and less blood loss. Moreover, the rise in the population opting for minimally invasive surgical procedures and the adoption of these techniques by several healthcare providers is generating profitable opportunities for the market players involved in the minimally invasive surgery market.

Market Segmentation

Segmentation Analysis of Minimally Invasive Surgery Market:

Depending on device, the surgical device segment is anticipated to dominate the minimally invasive surgery market during the projected period. More than 59 million surgical procedures are performed every year in the US, and out of which, 85 percent utilize electrosurgical devices. These devices are frequently utilized during surgical operations such as eye surgery to cut, coagulate, dissect, fulgurate, ablate and shrink tissue. Surgical devices play an important part in minimally invasive surgery procedures thus, driving the growth of the segment. Surgical device segment is expected to reach US$ 47 billion by the end of the analysis period.

Depending on the surgery method, the traditional segment is expected to lead the minimally invasive surgery market in the projected period. The cost involved in the traditional method of laparoscopic surgery is low as compared to robotic laparoscopic. Moreover, the traditional method requires less training period and can be easily administered by medical professionals thus, supporting the development of this segment. The robot-assisted segment is predicted to have a significant growth rate in the forecast period. The technological advancement and the growing research and development activities in robotics are the main factors stimulating the development of this segment. The da Vinci surgical system developed by Intuitive Surgical is the most advance robotic system utilized for minimally invasive surgery procedures. Many hospitals around the globe have added da Vinci surgical system to upgrade their medical services thus, promoting the growth of this segment.

Depending on surgery type, the orthopedic segment is forecasted to have the highest share of the minimally invasive surgery market. With the rise in the aging population, there is an increase in orthopedic patients, with 6.6 million orthopedic surgeries occurring annually by 2020. Moreover, orthopedic issues are the most common reason for which individuals seek medical care, with one in seven Americans reporting an orthopedic-related disorder the demand for minimally invasive orthopedic surgeries is going to increase in the forecast period.

Depending on end-users, the hospital segment is forecasted to be the prominent shareholder of the minimally invasive surgery market. With the majority of individuals preferring hospitals for surgical procedures due to highly skilled healthcare professionals, the demand for minimally invasive surgery methods has seen a rise. In addition, other essential medical facilities are provided under one roof. Furthermore, patients are more satisfied while getting treated in hospitals thus, promoting the expansion of this segment.

Regional Analysis of Minimally Invasive Surgery Market:

North America leads the global market for Minimally Invasive Surgery (MIS), driven by its advanced healthcare infrastructure, high patient awareness, and significant investments in surgical technology. The United States is at the forefront, with extensive adoption of MIS procedures in various medical fields, including cardiology, orthopedics, and gynecology. The presence of key industry players such as Intuitive Surgical, Stryker, and Medtronic contributes to the rapid integration of cutting-edge technologies like robotic-assisted surgery and advanced imaging systems. The region also benefits from a favorable regulatory environment and substantial funding for research and development, enabling continuous innovation in MIS techniques and devices. Canada also plays a crucial role, particularly in developing and implementing laparoscopic and endoscopic procedures, supported by a well-structured healthcare system and increasing investments in medical technology.

The global Minimally Invasive Surgery (MIS) industry exhibits varied levels of adoption and growth across different regions. North America and Europe lead in terms of technological advancements and market penetration, driven by robust healthcare infrastructure and a focus on innovation. Asia-Pacific shows the fastest growth, propelled by demographic trends and rapid healthcare development. Latin America and the Middle East & Africa present emerging markets with growing potential, although they face challenges related to infrastructure and economic disparities.

Players Covered in Minimally Invasive Surgery Market are:

• NuVasive Inc (US)
• Siemens Healthineers (Germany)
• Stryker Corporation (US)
• Teleflex Inc. (US)
• Intuitive Surgical (US)
• Beverly Hills Orthopedic Institute (US)
• Boston Center for Ambulatory Surgery Inc. (US)
• Weill Cornell Medicine (US)
• Smart Medical Devices Inc. (US)
• Taiwan Surgical Corporation (Taiwan)
• Tissium (France)
• ZSX Medical LLC (US)
• Ancillary Advantage Inc. (US) and other major players.

Recent Industry Developments in Minimally Invasive Surgery Market:

• In March 2024, Medtronic plc a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.
• In March 2024, Siemens Healthineers developed the Ciartic Move3 automated C-arm system for intraoperative imaging in surgery. The system features holonomic, omnidirectional wheels for precise movements and easy positioning. It can be moved to previously stored positions with a touch of a button using a remote control, reducing the burden on technologists. The automated process saves time by making automatic adjustments more precise, reducing imaging times by around 50% in spine, pelvic, and distal radius surgery
• In June 2024, Intuitive Surgical (NASDAQ: ISRG) secured FDA clearance for its fifth generation da Vinci 5 robotic system, enhancing minimally invasive surgery with over 150 technological advancements. Key features include improved precision, 3D imaging, and novel Force Feedback technology, promising better surgical outcomes and workflow efficiency. This innovation signifies a leap forward for robotic-assisted surgery, aiming to reduce surgical trauma and optimize operating room performance.